Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice

Prostate

Volumn 42, Issue 4, 2000, Pages 304-314

  Bylund, Annika ^a   Zhang, Jie Xian ^a   Bergh, Anders ^a   Damber, Jan Erik ^a   Widmark, Anders ^a   Johansson, Anders ^a   Herman, Adlercreutz ^b   Åman, Per ^c   Shepherd, Martin J ^d   Hallmans, Göran ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^d Central Science Laboratory   (United Kingdom)

Author keywords

Nude mice; Phytoestrogens; Prostate adenocarcinoma; PSA; Rye; Soy

Indexed keywords

PHYTOESTROGEN; PROSTATE SPECIFIC ANTIGEN; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAN; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DIET; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL DIVISION; DIETARY FIBER; DIETARY PROTEINS; EATING; ESTROGENS, NON-STEROIDAL; HUMANS; ISOFLAVONES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NECROSIS; NEOPLASM TRANSPLANTATION; PHYTOESTROGENS; PLANT PREPARATIONS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SECALE CEREALE; SOYBEAN PROTEINS;

EID: 0033950969     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(20000301)42:4<304::AID-PROS8>3.0.CO;2-Z     Document Type: Article

References (49)

1. Yatani R, Chigusa I, Akazaki K, Stemmermann GN, Welsh RA, Correa P. Geographic pathology of latent prostatic carcinoma. Int J Cancer 1982;29:611-616.
2. Pukkalam E, Gustavsson N, Teppom L. Atlas of cancer incidence in Finland. Helsinki: Offset/PKK Oy; 1987. p 37.
3. Kleemola P, Virtanen M, Pietinen P. The 1992 dietary survey of Finnish adults. Helsinki: Helsinki National Public Health Institute, Dept of Nutrition; 1994.
4. Westin P, Brändström A, Damber JE, Bergh A. Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma. Br J Cancer 1995;72:140-145.
5. Landstrom M, Damber JE, Bergh A. Estrogen treatment postpones the castration-induced dedifferentiation of Dunning R3327-PAP prostatic adenocarcinoma. Prostate 1994;25:10-18.
6. Huggins C, Hodges CV. Studies on prostatic cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941;1:293-297.
7. Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer 1991;16:43-52.
8. Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997;29:95-120.
9. Makela SI, Pylkkanen LH, Santti RS, Adlercreutz H. Dietary soybean may be antiestrogenic in male mice. J Nutr 1995;125: 437-445.
10. Zhang JX, Hallmans G, Landstrom M, Bergh A, Damber JE, Aman P, Adlercreutz H. Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats. Cancer Lett 1997;114:313-314.
11. Naik HR, Lehr JE, Pienta KJ. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. Anticancer Res 1994;14:2617-2619.
12. Lim DJ, Liu XL, Sutkowski DM, Braun EJ, Lee C, Kozlowski JM. Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude mice. Prostate 1993;22:109-118.
13. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy P. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43:1809-1818.
14. Janik P, Briand P, Hartmann NR. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res 1975;35: 3698-3704.
15. Mazur W, Fotsis T, Wahala K, Ojala S, Salakka A, Adlercreutz H. Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal Biochem 1996;233:169-180.
16. Adlercreutz H, Fotsis T, Bannwart C, Wahala K, Brunow G, Hase T. Isotope dilution gas chromatographic-mass spectrometric method for the determination of lignans and isoflavonoids in human urine, including identification of genistein. Clin Chim Acta 1991;199:263-278.
17. Adlercreutz H, Fotsis T, Kurzer MS, Wahala K, Makela T Hase T. Isotope dilution gas chromatographic-mass spectrometric method for the determination of unconjugated lignans and isoflavonoids in human feces, with preliminary results in omnivorous and vegetarian women [published erratum appears in Anal Biochem 1995.] Anal Biochem 1995;225:101-108.
18. Wisjman J, Jonker R, Kejzer R, van de Velde C, Cornelisse C, van Dierendonck J. A new method to detect apoptosis in paraffin sections: in situ end labeling of fragmented DNA. J Histochem Cytochem 1993;41:7-12.
19. Kerr J, Searle J. deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch Cell Pathol 1973;13:87-102.
20. Shimizu H, Ross R, Bernstein L, Yatani R, Henderson B, Mack T. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991;63:963-966.
21. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamalainen E, Hasegawa T, Okada H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 1991;54:1093-1100.
22. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993;342: 1209-1210.
23. Mills P, Beeson B, Phillips R, Fraser G. Cohort study of diet, lifestyle and prostate cancer in Adventist men. Cancer 1989;64: 598-604.
24. Severson R, Nomura A, Grove J, Stemmermann G. A prospective study of demographies, diets and prostatic cancer among man of Japanese ancestry in Hawaii. Cancer Res 1989;49:1857-1860.
25. Herbert J, Hurley T, Olendzki B, Yunsheng J, Hampl J. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst 1998;90: 1637-1647.
26. Adlercreutz H, Mäkelä S, Pylkkänen L, Santti R, Kinzel J, van Reijsen M. Dietary phytoestrogens and prostate cancer. 86th Annual Meeting of the American Association for Cancer Research, 1995. p 687.
27. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe SI, Itoh N, Shibuya M, Fukami Y. Genistein a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5595.
28. Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995;Suppl 790.
29. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R, Schweigerer L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 1997;57:2916-2921.
30. Markovitz J, Linassier C, Fosse P, Couprie J, Pierre J, JacqeminSablon A, Saucier JM, Le Pecq JB, Larson AK. Inhibitory effects of tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 1989;49:5111-5117.
31. Furusato M, Wakui S, Sasaki H, Ito K, Ushigome, S. Tumour angiogenesis in latent prostatic carcinoma. Br J Cancer 1994;70: 1244-1246.
32. Evans BA, Griffiths K, Morton MS. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995;147:295-302.
33. Denmeade SR, Lin XS, Isaacs JT. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 1996;28:251-265.
34. Stephens FO. Phytoestrogens and prostate cancer: possible preventive role. Med J Aust 1997;167:138-140.
35. Landström M, Zhang J, Hallmans G, Åman P, Bergh A, Damber J, Mazur W, Wähälä K, Adlercreutz H. Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate 1998;36:151-161.
36. Pretlow T, Delmoro C, Dilley G, Spadafora C, Pretlow T. Transplantation of human prostatic carcinoma into nude mice in matrigel. Cancer Res 1991;51:3814-3817.
37. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4.
38. Landström M, Damber J, Bergh A. Prostatic tumour regrowth after initially successful castration therapy may be related to a decreased apoptotic cell death rate. Cancer Res 1994;54:4281-4284.
39. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996;2:689-692.
40. Kyle E, Neckers L, Takimoto C, Curt G, Bergan R. Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol Pharmacol 1997;51:193-200.
41. Strom S, Yamamura Y, Duphorne C, Spitz M, Babaian R, Pillow P, Hursting S. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nut Cancer 1999;33:20-25.
42. Winata A, Lorenz K. Antioxidant potential of 5-n -pentadecyl-resorcinol. Food Processing and Preservation 1996; 20: 417-429.
43. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, Haapakoski J, Malila N, Rautalahti M, Ripatti S, Maenpaa H, Teerenhovi L, Koss L, Virolainen M, Edwards BK. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-446.
44. Weindruch R, Albanes D, Kritchevsky D. The role of calories and caloric restriction in carcinogenesis. Hematol Oncol Clin North Am 1991;5:79-89.
45. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet:see comments. J Natl Cancer Inst 1995;87.1456-1462.
46. Pollard M, Luckert PH. Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett 1986;32:223-227.
47. Kondo Y, Homma Y, Aso Y, Kakizoe T. Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats. Cancer Res 1994;54:6129-6132.
48. Harvei S, Bjerve K, Tretli S, Jellum E, Robsahm T, Vatten L. Prediagnostic level of fatty acids in serum phospholipids: -3 and -6 fatty acids and the risk of prostate cancer. Int J Cancer 1997; 71:545-551.
49. Andersson S, Wolk A, Bergstrom R, Adami H, Engholm G, Englund A, Nyren O. Body size and prostate cancer- A 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 1997;89:385-389.